Therapy of leukocyte dysfunction during sepsis;Therapie der Leukozytendysfunktion bei Sepsis

Intensivmedizin und Notfallmedizin

Volumn 33, Issue 6, 1996, Pages 386-398

  Thiel, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

adhesion molecules; cAMP; G CSF; GM CSF; inhibition; neutrophils; sepsis; stimulation

Indexed keywords

ADENOSINE; ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PENTOXIFYLLINE; PROSTAGLANDIN E;

CELL PROLIFERATION; HUMAN; LEUKOCYTE DISORDER; NEUTROPHIL; NONHUMAN; REVIEW; SEPSIS;

EID: 0029783586     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Bone RC (1991) A critical evaluation of new agents for the treatment of sepsis. JAMA 266:1686-1691
2. Bone RC, Balk RA, Cerra FB (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/ SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655
3. Boogaerts MA, Malbrain S, Meeus P, van Hove L, Verhoef GE (1990) In vitro modulation of normal and diseased human neutrophil function by pentoxifylline. Blut 61:60-65
4. Cronstein BN, Haines KA (1992) Stimulus-response uncoupling in the neutrophil. Adenosine A2-receptor occupancy inhibits the sustained, but not the early. events of stimulus transduction in human neutrophils by a mechanism independent of actin-filament formation. Biochem J 281:631-635
5. Currie MS, Rao KMK, Padmanabhan J, Jones A. Crawford J, Cohen HJ (1990) Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and superoxide production. J Leukocyte Biol 47:244-250
6. Dahlgren C, Aniansson H. Magnusson KE (1985) Pattern of formylmethionyl-leucyl-phenylalanine-induced luminol-and lucigenin-dependent chemiluminescence in human neutrophils. Infect Immun 47:326-328
7. Dahlgren C. Stendahl O (1983) Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocyte. Infect Immun 39:736-741
8. Doecke WD, Syrbe U, Meinecke A (1994) Improvement of monocyte function - a new therapeutic approach? In: Reinhart et al (eds) Sepsis. Springer Verlag, pp 473-488
9. Doerschuk CM, Winn RK, Coxson HO. Harlan JM (1990) CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol 144:2327-2333
10. Eichacker PQ, Waisman Y, Natanson C (1994) Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 77:2366-2373
11. Eichacker PQ, Farese A, Hoffman WD (1992) Leukocyte CD11b/18 antigendirected monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor. Am Rev Respir Dis 145:1023-1029
12. Eichacker PQ, Hoffman WD, Farese A (1993) Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shock. J Appl Physiol 74:1885-1892
13. Endo S, Inada K, Inoue Y (1994) Evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy in granulopoetic patients complicated with sepsis. Curr Med Res Opin 13:233-241
14. Firestein GS, Boyle D, Bullough DA (1994) Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol 152:5853-5859
15. Follin P, Dahlgren C (1992) Phagocytosis by lipopolysaccharide-primed human neutrophils is associated with increased extracellular release of reactive oxygen metabolites. Inflammation 16:83-91
16. Foster PF, Mital D, Sankary HN (1995) The use of granulocyte colony-stimulating factor after liver transplantation. Transplantation 59:1557-1563
17. Frenck RW, Sarman G, Harper TE, Buescher ES (1990) The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus. J Infect Dis 162:109-114
18. Friedman G (1995) Metaanalysis of letality in septic patients. 15th International Symposium on Intensive Care and Emergency Medicine.
19. Garcia NM, Mileski WJ, Sikes P (1994) Effect of inhibiting leukocyte integrin (CD18) and selectin (L-selectin) on susceptibility to infection with Pseudomonas aeruginosa. J Trauma 36:714-718
20. Gennari R, Alexander JW, Gianotti L, Eaves Pyles T, Hartmann S (1994) Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance. Ann Surg 220:68-76
21. Granger DN, Kubes P (1994) The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukocyte Biol 55: 662-675
22. Hand WL, Butera ML, King Thompson NL, Hand DL (1989) Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes. Infect Immun 57:3520-3526
23. Hardart GE, Sullivan GW, Carper HT, Mandell GL (1991) Adenosine and 2-phenylaminoadenosine (CV-1808) inhibit human neutrophil bactericidal function Infect Immun 59:885-889
24. Hebert JC, O'Reilly M, Gamelli RL (1990) Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 125:1075-1078
25. 2. Naunyn-Schmiedeberg's Arch Pharmacol 341:308-315
26. Hughes BJ, Hollers JC, Crockets-Torabi E, Smith CW (1992) Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest 90:1687-1696
27. Jaeschke H, Farhood A, Smith CW (1991) Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 261:G1051-G1056
28. Krause PJ, Maderazo EG, Contrino J (1991) Modulation of neonatal neutrophil function by pentoxifylline. Pediatric Research 29:123-127
29. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263:5380-5384
30. Lauterbach R, Pawlik D, Tomaszczyk B. Cholewa B (1994) Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations. Eur J Pediatr 153:672-674
31. Le Vraux V, Chen YL, Masson I (1993) Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci 52:1917-1924
32. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med 327:28-35
33. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulatina factor (2). N Engl J Med 327:99-106
34. Lundblad R, Ekström P, Giercksky KE (1995) Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intraabdominal sepsis in rats. Shock 3:210-215
35. Matrai A, Ernst E (1988) Verbesserung der Leukozytenrheologie durch Pentoxifyllin. Medizinische Klinik 83:45-47
36. Mileski WJ, Sikes P, Atiles L, Lightfoot E, Lipsky P, Baxter C (1993) Inhibition of leukocyte adherence and susceptibility to infection. J Surg Res 54:349-354
37. Montgomery B, Bianco JA, Jacobsen A, Singer JW (1991) Localization of transfused neutrophils to site of infection during treatment with recombinant human granulocyte-macrophage-colony-stimulating factor and pentoxifylline. Blood 78:533-534
38. Morrissey PJ, Charrier K (1990) GMCSF administration augments the survival of ity-resistant A/J mice, but not ity-susceptible C57BL/6 mice, to a lethal challenge with Salmonella typhimurium. J Immunol 144:557-561
39. Nelson S, Summer W, Bagby G (1991) Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 164:901-906
40. Nishida Y, Honda Z, Miyamoto T (1987) Suppression of human polymorphonuclear leukocyte phagocytosis by adenosine analogs. Inflammation 11:365-369
41. O'Reilly M, Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC (1992) Treatment of intraabdominal infection with granulocy te colony-stimulating factor. J Trauma 33:679-682
42. Peters WP, Stuart A, Affronti ML, Kim CS, Coleman RE (1988) Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans. Blood 72:1310-1315
43. Rao KMK, Crawford J, Currie MS, Cohen HJ (1988) Depolymerization of actin and inhibition of ligand-induced capping in human lymphocytes and neutrophils by pentoxifylline. Clin Res 36:368 A
44. Richter J (1992) Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils. J Leukocyte Biol 51:270-275
45. Ridings PC, Windsor AC, Sugerman HJ (1994) Beneficial cardiopulmonary effects of pentoxifylline in experimental sepsis are lost once septic shock is established Arch Surg 129:1144-1152
46. Schade UF (1990) Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circulatory Shock 31:171-181
47. Sharar SR, Winn RK, Murry CE, Harlan JM, Rice CL (1991) A CD18 monoclonal antibody increases the incidence and severity of subcutaneous abscess formation after high-dose Staphylococcus aureus injection in rabbits. Surgery 110:213-219
48. Smith RM, Woodman RC, Babior BM (1991) In: Harris JR (ed) Blood Cell Biochemistry: Lymphocytes and Granulocytes. Plenum Press, London, pp 215-254
49. Stadler J, Heidecke CD, Bartels H, Holzmann B, Wagner H, Siewert JR (1995) Immunosuppression and infection. Chirurg 66:11-17
50. Stricter RM, Temick DG, Ward PA (1988) Cellular and molecular regulation of tumor necrosis factor alpha production by pentoxifylline. Biochem Biophys Res Commun 155:1230-1236
51. Sullivan GW, Linden J, Hewlett EL, Carper HT, Hylton JB, Mandell GL (1990) Adenosine and related compounds counteract tumor necrosis factor-α inhibiton of neutrophil migration: implication of a novel cylcic amp-independent action on the cell surface. J Immunol 145:1537-1544
52. Sullivan GW, Patselas TN, Redick JA, Mandell GL (1984) Enhancement of chemotaxis and protection of mice from infection. Trans Assoc Am Physicians 97:337-345
53. Thiel M, Bardenheuer H (1992) Regulation of oxygen radical production of human polymorphonuclear leukocytes by adenosine: the role of calcium. Pflügers Archiv 420:522-528
54. Thiel M, Bardenheuer H, Pöch G, Madel C, Peter K (1991) Pentoxifylline does not act via adenosine receptors in the inhibition of the Superoxide anion production of human polymorphonuclear leukocytes. Biochem Biophys Res Commun 180:53-58
55. Thiel M, Chambers JD, Chouker A, Fischer S, Zourelidis C, Bardenheuer H, Arfors KE, Peter K (1996) Effect of adenosine on the expression of β2-integrins and 1-selectin of polymorphonuclear leukocytes in vitro. J Leukocyte Biol. in press:
56. Thiel M, Chouker A (1995) Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-α of endotoxin-stimulated human polymorphonuclear leukocytes. J Clin Lab Med 124:275-282
57. Tuomanen EI, Saukkonen K, Sande S, Cioffe C, Wright SD (1989) Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 170:959-969
58. Walsh CJ, Carey PD, Cook DJ, Bechard DE, Fowler AA, Sugerman HJ (1991) Anti-CD18 antibody attenuates neutropenia and alveolar capillary membrane injury during gram-negative sepsis. Surgery 110:205-212
59. Yasuda H, Ajiki Y, Shimozato T (1990) Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun 58:2502-2509